Form 4 for TCRT Alaunos Therapeutics, Inc.
Accepted 2025-08-20 00:00:00 ET · period of report 2025-08-18 · accession 0000950170-25-110531 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-20 | 2025-08-18 | TCRT | Groenewald Ferdinand | VP of Fin | A - Grant | $0.00 | +10.8K | 10.8K | New | $0 |
| D | 2025-08-20 | 2025-08-18 | TCRT | Groenewald Ferdinand | VP of Fin | A - Grant | $0.00 | +4,000 | 4,000 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-18 | A | A | 10,775 | $0.00 | 10,775 | D | — | — | |
| 2 | Derivative | Employee Stock Option (right to buy) | 2025-08-18 | A | A | 4,000 | $0.00 | 4,000 | D | $2.32 · — to 2035-08-17 | 4,000 Common Stock | (F1) One-sixteenth of the shares underlying the option vest in equal quarterly installments measured from August 18, 2025, with the first vesting occurring on November 18, 2025 subject to the Reporting Person's continued service through each vesting date. |